EIF5A and hepatocellular carcinoma: Based on our previous study and other studies, it is proposed that eukaryotic translation initiation factors (eIFs) constitute a potential class of therapeutic targets for treatment of various cancers, and this paper will focus on discussing the implications of using eukaryotic translation initiation factor 5A (eIF5A) as a prognostic marker and treatment target in HCC.